For his research on liquid biopsies 🩸🧬 in #neuroendocrine cancer 🦓 NETwerk coordinator Timon Vandamme received the prestigious FWO Senior Clinical Research fellowship. Exciting research 🔬within our #ENETS Center of Excellence! UAntwerpen UZA

Vandaag wierp ik een blik in de toekomst over diagnose en behandeling van #netkanker met patiënt centraal op 10 jaar vzw NET&MEN infodag, de Belgische patiëntenvereniging, samen met Gerolf Valk UMC Utrecht en Mark McDonnell NET Cancer Day. #letstalkaboutnets NETwerk NETNECkanker

Effects of the COVID-19 pandemic on NET management published in JNE. Thanks to the authors Mauro Cives, J Hernando, Angela Lamarca, Catherine Bouvier Ellis Neuroendocrine Cancer UK #NotJustNECancer, Prof Martyn Caplin, Prof Pavel. Thanks also to INCA & NANETS cor2ed.com/net-connect/pr… #LetsTalkAboutNETs

📰Hot off the press! Thrilled to share our Journal of Clinical Oncology #RapidPub of a Randomized Study of Tem or CapeTem in Pts with Advanced Pancreatic Neuroendocrine Tumors (ECOG-ACRIN E2211) 1/ ascopubs.org/doi/10.1200/JC…

Ook in ons Centrum voor Oncologisch Onderzoek CORE UAntwerpen is het vandaag #dagtegenkanker 🎗 Onze missie? Betere genezing en levenskwaliteit van kankerpatiënten door snelle opsporing en nieuwe revolutionaire therapieën 🔬👩‍🔬👨‍🔬

Vandaag organiseert Kom op tegen Kanker (vzw) de Dag tegen Kanker. Niet alleen tegen kanker maar vooral vóór patiënten met #NET en andere kankers. De patiënten en hun naasten worden daarom in alle NETwerk centra extra in de bloemetjes gezet!

#dagtegenkanker dank Jean Bosco Safari voor een prachtoptreden op dagzaal oncologie Jan Palfijn, Antwerpen! ZNA-Woordvoerder

📢Today is #NETCancerDay! Created by INCA over 10 years ago, #NETCancerDay is held to raise awareness and improve NET diagnostics and care. Know the Symptoms. Push for Diagnosis! 📌Join us and spread the word: ▶incalliance.org/ncd-2022/ #LetsTalkAboutNETs #MedTwitter #OncoTwitter

Interesting paper delving into #neuroendocrinecancer heterogeneity. Using 42 samples of a single patient, Tamsin Robb shows different clones in different metastatic sites. Would this be driven by treatment 🤔?

This is going to be a very interesting topic! Looking forward to what Jaume Capdevila and Mauro Cives will share with us! Join us on this great discussion. #Webinars ENETS N&D Group

Proud and excited to share the start of the SAUNA trial, an academia-initiated RCT in 20 🏥🏨🏩 in 🇳🇱🇧🇪 headed by NETwerk Timon Vandamme and Erasmus MC: continue SSA💉 or not in 2nd line for non-functioning GEP NET🦓 ZonMw @kcefgpv annemiek walenkamp Koen Dreijerink clinicaltrials.gov/ct2/show/NCT05…

🔬 In ons universitair #kanker-onderzoekscentrum CORE CORE UAntwerpen UZA werken we aan nieuwe behandelingen van de toekomst, op maat van de patiënt. Graag eens een kijkje? 🎬👇 Meer info: oncopolis.be Retweet gerust, het is tenslotte hoopvol nieuws.

Quite possibly the best review of functional pancreatic neuroendocrine tumors (and their management) that I've ever read Bravo ENETS! onlinelibrary.wiley.com/doi/10.1111/jn…

Kick-off congress DBNETS (Dutch Belgian Neuroendocrine Tumor Society) Rotterdam#Hans Hofland#settling the scopes👊👊👍👍

DBNETS Rotterdam#Annemiek Walenkamp NET expert#always enthousiastic and expiring talks💥💥

Vanavond mochten we, samen met Vzw NET en MEN Kanker Belgium, een praatje houden over ons werk voor de patiënten bij het DB-nets congres in Rotterdam. DB-nets is een samenwerking van alle Nederlandse en Belgische kenniscentra voor NET en NEC.

Really enjoyed the first Dutch Belgian NET Society conference. Truely a constructive, collaborative and relaxing atmosphere. Thanks to the amazing board and all participants DBNETS annemiek walenkamp Timon Vandamme Koen Dreijerink NETNECkanker Willem Lybaert Christophe Deroose Jules Derks, MD, PhD Anne-Marie Dingemans

What is the carcinoid syndrome😳? Many mediators have been postulated, but what is truly the evidence? See our new review Endocrine Society Journals academic.oup.com/edrv/advance-a… Erasmus MC DBNETS Neuroendocrine Cancer

Today is all about #neuroendocrinecancer at #ENDIMET2024, the largest medical conference in Colombia with 3000+ participants. Happy to be invited to talk about the NET treatment algorithm and the role of somatostatin analogues in grade 3 NET @aceendocrino #launiónhACElafuerza

Willem Lybaert Mauro Cives Thor Halfdanarson First-line trial with DLL3-BITE and carbo/eto for extra-pulmonary neuroendocrine carcinoma and large cell NEC of lung currently open and recruiting in UZA & NETwerk. Hopefully promise will be translated to new standard-of-care in this hard-to-treat cancer!